Geriatrics 2030: Developing Drugs to Care for Older Persons—A Neglected and Growing Population-Reference-Cited by-同舟云学术

Geriatrics 2030: Developing Drugs to Care for Older Persons—A Neglected and Growing Population

Published:2019-10-30 Issue:1 Volume:107 Page:53-56
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Lau S.W. Johnny¹,Schlender Jan‐Frederik²,Slattum Patricia W.³,Heald Donald L.⁴,O'Connor‐Semmes Robin⁵

Affiliation:

1. Office of Clinical Pharmacology Office of Translational Sciences Center for Drug Evaluation and Research US Food and Drug Administration Silver Spring Maryland USA

2. Systems Pharmacology and Medicine Bayer AG Leverkusen Germany

3. Department of Pharmacotherapy and Outcomes Science Virginia Commonwealth University Richmond Virginia USA

4. Discovery Translational Research Biologics Development Sciences Janssen Biotherapeutics Spring House Pennsylvania USA

5. Quantitative Clinical Development Parexel International Durham North Carolina USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1663

Reference10 articles.

1. United Nations Department of Economic and Social Affairs Population Division.World Population Ageing 2017 (ST/ESA/SER.A/408) (2017). Accessed September 16 2019.

2. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults

3. Rational Prescribing for Patients With a Reduced Life Expectancy

4. Bruyère Research Institute.What is deprescribing?. Accessed September 16 2019.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08

2. Physiologically based pharmacokinetic (PBPK) modelling of oral drug absorption in older adults – an AGePOP review;European Journal of Pharmaceutical Sciences;2023-09

3. Physiologically Based Pharmacokinetic Model for Older Adults and Its Application in Geriatric Drug Research;Current Drug Metabolism;2023-03

4. Physiologically-based pharmacokinetic modeling to predict drug-drug interactions of dabigatran etexilate and rivaroxaban in the Chinese older adults;European Journal of Pharmaceutical Sciences;2023-03

5. Cardiovascular Pharmacology of the Older Patient;Contemporary Cardiology;2023